Cutaneous Protothecosis Responds Rapidly To Voriconazole

International Journal of DermatologyVolume 55, Issue 12 p. 1373-1377 Case Report Cutaneous protothecosis responds rapidly to voriconazole Chul Hyun Yun MD, Chul Hyun Yun MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJi Hun Jeong MD, PhD, Ji Hun Jeong MD, PhD Department of Laboratory Medicine, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorHa Ryeong Ryu MD, Ha Ryeong Ryu MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJi Hoon Kim MD, Ji Hoon Kim MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJin Ok Baek MD, Jin Ok Baek MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJong Rok Lee MD, PhD, Jong Rok Lee MD, PhD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorYiel Hea Seo MD, PhD, Yiel Hea Seo MD, PhD Department of Laboratory Medicine, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJoo Young Roh MD, PhD, Corresponding Author Joo Young Roh MD, PhD [email protected] Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South Korea Correspondence Joo Young Roh, md, phd Department of Dermatology Gachon University School of Medicine Gil Medical Center 1198 Guwol-Dong Namdong-Gu Incheon 405-760 South Korea E-mail: [email protected]Search for more papers by this author Chul Hyun Yun MD, Chul Hyun Yun MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJi Hun Jeong MD, PhD, Ji Hun Jeong MD, PhD Department of Laboratory Medicine, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorHa Ryeong Ryu MD, Ha Ryeong Ryu MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJi Hoon Kim MD, Ji Hoon Kim MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJin Ok Baek MD, Jin Ok Baek MD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJong Rok Lee MD, PhD, Jong Rok Lee MD, PhD Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorYiel Hea Seo MD, PhD, Yiel Hea Seo MD, PhD Department of Laboratory Medicine, Gil Medical Center, Gachon University School of Medicine, Incheon, South KoreaSearch for more papers by this authorJoo Young Roh MD, PhD, Corresponding Author Joo Young Roh MD, PhD [email protected] Department of Dermatology, Gil Medical Center, Gachon University School of Medicine, Incheon, South Korea Correspondence Joo Young Roh, md, phd Department of Dermatology Gachon University School of Medicine Gil Medical Center 1198 Guwol-Dong Namdong-Gu Incheon 405-760 South Korea E-mail: [email protected]Search for more papers by this author First published: 23 December 2015 https://doi.org/10.1111/ijd.13160Citations: 4 Conflicts of interests: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Boyd AS, Langley M, King LE Jr. Cutaneous manifestations of Prototheca infections. J Am Acad Dermatol 1995; 32: 758–764. 2Kim ST, Suh KS, Chae YS, et al. Successful treatment with fluconazole of protothecosis developing at the site of an intralesional corticosteroid injection. Br J Dermatol 1996; 135: 803–806. 3Kuo TT, Hseuh S, Wu JL, et al. Cutaneous protothecosis. A clinicopathologic study. Arch Pathol Lab Med 1987; 111: 737–740. 4Lass-Florl C, Mayr A. Human protothecosis. Clin Microbiol Rev 2007; 20: 230–242. 5Chao SC, Hsu MM, Lee JY. Cutaneous protothecosis: report of five cases. Br J Dermatol 2002; 146: 688–693. 6Goldstein GD, Bhatia P, Kalivas J. Herpetiform protothecosis. Int J Dermatol 1986; 25: 54–55. 7Iacoviello VR, DeGirolami PC, Lucarini J, et al. Protothecosis complicating prolonged endotracheal intubation: case report and literature review. Clin Infect Dis 1992; 15: 959–967. 8McAnally T, Parry EL. Cutaneous protothecosis presenting as recurrent chromomycosis. Arch Dermatol 1985; 121: 1066–1069. 9Wolfe ID, Sacks HG, Samorodin CS, et al. Cutaneous protothecosis in a patient receiving immunosuppressive therapy. Arch Dermatol 1976; 112: 829–832. 10Lee WSKY, Kim SY, Kim KM. A case of cutaneous protothecosis. Korean J Dermatol 2006; 44: 648–651. 11Figueroa CJ, Camp BJ, Varghese GI, et al. A case of protothecosis in a patient with multiple myeloma. J Cutan Pathol 2014; 41: 409–413. 12Kwong JC, Ward PB, Johnson PD. Cutaneous protothecosis in a patient with hypogammaglobulinemia. Med Mycol Case Rep 2013; 2: 132–133. 13Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216–1223. 14Davies RR, Spencer H, Wakelin PO. A case of human protothecosis. Trans R Soc Trop Med Hyg 1964; 58: 448–451. 15Zak I, Jagielski T, Kwiatkowski S, et al. Prototheca wickerhamii as a cause of neuroinfection in a child with congenital hydrocephalus. First case of human protothecosis in Poland. Diagn Microbiol Infect Dis 2012; 74: 186–189. 16Sudman MS, Majka JA, Kaplan W. Primary mucocutaneous protothecosis in a dog. J Am Vet Med Assoc 1973; 163: 1372–1374. 17Nosanchuk JS, Greenberg RD. Protothecosis of the olecranon bursa caused by achloric algae. Am J Clin Pathol 1973; 59: 567–573. 18Todd JR, King JW, Oberle A, et al. Protothecosis: report of a case with 20-year follow-up, and review of previously published cases. Med Mycol 2012; 50: 673–689. 19Torres HA, Bodey GP, Tarrand JJ, et al. Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect 2003; 9: 786–792. 20Cho BK, Ham SH, Lee JY, et al. Cutaneous protothecosis. Int J Dermatol 2002; 41: 304–306. 21Follador I, Bittencourt A, Duran F, et al. Cutaneous protothecosis: report of the second Brazilian case. Rev Inst Med Trop Sao Paulo 2001; 43: 287–290. 22Jones JW, McFadden HW, Chandler FW, et al. Green algal infection in a human. Am J Clin Pathol 1983; 80: 102–107. 23Leimann BC, Monteiro PC, Lazera M, et al. Protothecosis. Med Mycol 2004; 42: 95–106. 24Otoyama K, Tomizawa N, Higuchi I, et al. Cutaneous protothecosis – a case report. J Dermatol 1989; 16: 496–499. 25Elgart ML. Unusual subcutaneous infections. Dermatol Clin 1996; 14: 105–111. 26Mayhall CG, Miller CW, Eisen AZ, et al. Cutaneous protothecosis. Successful treatment with amphotericin B. Arch Dermatol 1976; 112: 1749–1752. 27Dalmau J, Pimentel CL, Alegre M, et al. Treatment of protothecosis with voriconazole. J Am Acad Dermatol 2006; 55(Suppl.): 122–123. 28Sheikh-Ahmad M, Goldstein S, Potasman I. Prototheca wickerhamii hand infection successfully treated by itraconazole and voriconazole. J Travel Med 2006; 13: 321–323. 29Sud IJ, Feingold DS. Lipid composition and sensitivity of Prototheca wickerhamii to membrane-active antimicrobial agents. Antimicrob Agents Chemother 1979; 16: 486–490. 30Blaschke-Hellmessen R. Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest. Mycoses 1996; 39(Suppl. 2): 39–43. 31Carey WP, Kaykova Y, Bandres JC, et al. Cutaneous protothecosis in a patient with AIDS and a severe functional neutrophil defect: successful therapy with amphotericin B. Clin Infect Dis 1997; 25: 1265–1266. 32Lass-Florl C, Fille M, Gunsilius E, et al. Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia. J Clin Microbiol 2004; 42: 4907–4908. 33Sands M, Poppel D, Brown R. Peritonitis due to Prototheca wickerhamii in a patient undergoing chronic ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13: 376–378. 34Segal E, Padhye AA, Ajello L. Susceptibility of Prototheca species to antifungal agents. Antimicrob Agents Chemother 1976; 10: 75–79. 35Peman J, Canton E, Calabuig E, et al. In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points. Rev Esp Quimioter 2006; 19: 21–33. 36Linares MJ, Solis F, Casal M. In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection. J Clin Microbiol 2005; 43: 2520–2522. Citing Literature Volume55, Issue12December 2016Pages 1373-1377 ReferencesRelatedInformation